Figure 7 shows that a low expression of IL12A was associated with a longer BCR-free survival (p=0.0196) while a high expression of CD163 was associated with a shorter time to definitive ADT (p=0.0203) and to lethal PCa (p=0.0323). These associations were confirmed by univariate Cox regression analysis. HR for these same associations were 0.26 (p=0.0298), 2.825 (p=0.0263) and 3.56 (p=0.0450), respectively (not shown). The gene discussed is IL12A; the disease is posterior cortical atrophy.